Protein Sciences Corporation


Sep 14, 09

NEW STORY
16:51 ET Bankruptcy Court Delaware Dismisses Involuntary Bankruptcy Case

 
Jun 15, 09

09:00 ET Commercial Manufacturing of H1N1 'Swine Flu' Vaccine Underway

 
Apr 30, 09

15:55 ET Protein Sciences Announces Signing of a Forbearance Agreement With Emergent BioSolutions

 
09:16 ET Protein Sciences Corporation Appoints New Board of Directors

 
Oct 24, 08

10:57 ET Vaxine Makes Unsolicited Bid to Acquire U.S. Company Protein Sciences Corporation

 
Jul 29, 08

13:32 ET Protein Sciences Announces Termination of Deal to Sell to Emergent BioSolutions

 
Jul 10, 08

14:52 ET Protein Sciences Responds to Emergent BioSolutions Lawsuit

 
Aug 29, 06

10:12 ET Protein Sciences Announces Licensing of FluBlOk(TM) to UMN Pharma for the Japan Market

 
Jan 09, 06

00:01 ET Protein Sciences Announces Closing of $6 Million Financing and Partnership in Diabetes Vaccine

 
Jun 14, 05

16:02 ET Protein Sciences Announces Excellent Efficacy Results for FluBlOk(TM), its Recombinant Influenza Vaccine

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2009 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.